GeneQuine
Develops novel therapies for osteoarthritis, a degenerative joint disease with high unmet medical need.
Launch date
Employees
Market cap
-
Enterprise valuation
CAD32—49m (Dealroom.co estimates Jan 2021.)
Company register number HRB 124958 (Hamburg)
Hamburg Germany (HQ)
Financials
Estimates*
| EUR | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|
| Profit | (<1m) | 1.2m | <1m | <1m | <1m | (2.8m) |
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | N/A | Seed | |
* | $64.0m Valuation: $64.0m | Acquisition | |
* | €5.4m | Series A | |
* | €3.7m | Convertible | |
| Total Funding | CAD13.6m | ||
Related Content
Recent News about GeneQuine
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.